HOME >> BIOLOGY >> NEWS
URI professor emeritus Saul B. Saila receives national award of excellence from American Fisheries Society

Biological oceanographer and URI professor emeritus Saul B. Saila has been given the Award of Excellence by the American Fisheries Society (AFS). The award is the oldest major AFS award and the most prestigious presented to an individual. Presented annually since 1969, it is given in recognition of outstanding science in the fields of fisheries and aquatic biology.

Saila has enriched the field of fishery science through innovative research and dedication to education in fifty years of professional service. He has pioneered the application of new analytical techniques in fisheries research, placing new tools in the hands of researchers that have substantially advanced the discipline in more than one hundred scientific papers and reports.

Saul is the recipient of numerous awards for his achievements, focusing on his roles as educator, researcher, and advisory, including several of the American Fisheries Societys highest awards, said Michael Fogarty of the Northeast Fisheries Science Center in Woods Hole, MA. It is fitting that the American Fisheries Society now recognizes a half century of commitment to excellence, dedication, and intellectual development with its highest award for professional excellence. Sauls journey as a scientist has indelibly left its mark on the field and on all those whose lives he has touched.

He was an early proponent of the development and utilization of quantitative models in fisheries applications. He recognized the revolution that computers would bring to the field from an early date and served as the director of the first computer center established at the University of Rhode Island, while continuing in his role as professor in the departments of Oceanography and Zoology.

He established the Marine Experiment Station at URI, modeled on the agricultural experiment stations of Land Grant Colleges. He later contributed to research areas as diverse as multispecies and ecosystem modeling, complex nonlinear dynamics, a
'"/>

Contact: Lisa Cugini
lcugini@gso.uri.edu
401-874-6642
University of Rhode Island
4-Sep-2001


Page: 1 2

Related biology news :

1. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
2. Virginia Tech professor honored with DeLaval Award
3. New and better drugs for tuberculosis goal of UH professor
4. UCSB professor and director receives two national awards
5. K-State professor combines love of teaching, research to examine eye development
6. LSU vet school professor uses gene therapy to destroy cancerous tumors
7. COPD is forgotten killer, says University of Toronto professor
8. Yale professor receives Johnson & Johnson Focused Giving award
9. UC Riverside professor to spend year with US State Department
10. UGA professor Jeffrey Bennetzen named to National Academy of Sciences
11. Four IU professors are 2004 Guggenheim Fellows

Post Your Comments:
(Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
(Date:10/16/2014)... cultivated efficiently, they are anything but sustainable: environmental ... cultivation is becoming increasingly evident. Despite their disadvantages, ... are regarded as the sole possibility of achieving ... finds Bernhard Schmid, an ecology professor at the ... of agriculture and forestry. After all, a new ...
(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
Breaking Biology News(10 mins):Modeling tumor dormancy 2Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Sandata Announces Case Study with Quality Care Services, Inc. 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. ... approximately 400 million people worldwide are living with diabetes, ... people by 2030.  The global market for diabetes treatments ... approximately 330,000 people worldwide died from pancreatic cancer.  Pancreatic ... due to cancer in the United States ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)... Md. , Oct. 20, 2014  GenVec, Inc. (NASDAQ: ... Zola P. Horovitz , Ph.D., from its board of directors ... board in August 2003, and served as its chairman from ... served on the Nominating and Corporate Governance and Audit Committees ... for more than a decade of dedicated service to GenVec, ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: